Emperical Comparative Study of GARCH Family Models for Stock Volatility Forecasting in India’s Pharma and IT Sectors
NA
Keywords:
GARCH Family Model, Co-efficient, Probability, Stock Volatility and E-ViewsAbstract
In this paper, we analyse the stock return volatility in the Pharma and IT sectors of India by employing GARCH family models ARCH, GARCH(1,1), TARCH(1,1), EGARCH(1,1), and PGARCH(1,1) to the daily stock returns from 2014 to 2025. The analysis aims to find the best model that accounts for volatility clustering and asymmetries within these sectors. The analysis demonstrates that while all models incorporated volatility clustering to some degree, asymmetrical models such as EGARCH(1,1) and PGARCH(1,1) did markedly better. In the IT sector, EGARCH(1,1) also outperformed all other models, achieving very significant results for INFOSYS (z = -10.47, p = 0.000) and TCS (z = -5.57, p = 0.000), and having lower AIC values (-4.803 for INFOSYS) and Log-Likelihood (6656.31 for TCS) scores. In the Pharma Sector, PGARCH(1,1) did outperform all models, CIPLA's Log-Likelihood of 7478.81 and AIC of -6.031. The results show that for sector-specific volatility forecasting, GARCH models proved more useful and provide better insight for investors and portfolio risk managers as well as supported strategic business decisions.
Published
How to Cite
Issue
Section
Copyright (c) 2025 kiran katepogu

This work is licensed under a Creative Commons Attribution 4.0 International License.
Allows users to: distribute and copy the article; create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: gives appropriate credit to the author(s) (with a link to the formal publication through the relevant URL ID); includes a link to the license; indicates if changes were made; and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation. CC BY



